Statins Combined with Stroke Prevention Drug Increase Risk of Haemorrhage
According to a study published in the Canadian Medical Association Journal (CMAJ), two commonly used statins can increase the risk of haemorrhage when combined with dabigatran etexilate, a stroke prevention drug used in patients with atrial fibrillation.
See Also: Statins and Drug-Drug Interactions: AHA Scientific Statement
A possible side effect of dabigatran etexilate is bleeding which can often turn out to be severe enough that the patient may have to visit the emergency department or may have to be admitted to the hospital. Two commonly used statins, lovastatin and simvastatin, could increase the amount of drug that is absorbed by the body thus increasing the risk of bleeding.
Two studies were conducted with patients over the age of 65 who were on dabigatran etexilate between 2012 and 2014. Out of a total of 45,991 patients, 397 cases of ischaemic stroke and 1117 cases of major haemorrhage were identified.
"We found no difference in the risk of stroke in patients receiving dabigatran etexilate who were prescribed lovastatin or simvastatin versus other statins," states Dr. Tony Antoniou, St. Michael's Hospital, Toronto, Ontario. "However, an increase in the risk of bleeding requiring hospital admission or emergency department visits was seen with lovastatin and simvastatin compared with the other statins."
The study findings indicate that there is a clinically important drug interaction between dabigatran etexilate and both simvastatin and lovastatin. Patients who are using this drug should thus be prescribed other statins to avoid any adverse clinical outcomes.
Image Credit: Wikimedia Commons
Published on : Tue, 22 Nov 2016
Unbelievably small and light mechanical chest compression device In case of a sudden cardiac arrest, immediate chest compressions are required. Performing manual chest compressions well for an extended period of time is almost impossible. Thanks to...
Automatic external defibrillator / with ECG monitor / public access FRED easyport SCHILLER
FRED easyport is an incredibly small and light pocket defibrillator, equipped with the effective and myocardium-saving defibrillation impulse called Multipulse Biowave. FRED easyport is the ideal companion for physicians, public service staff, even...
The CNAP® Monitor represents the next generation of noninvasive patient monitoring by merging the advantages of noninvasive, risk‐free methods with the benefits of continuity in the same accuracy as invasive standards. The advanced parameter set enables...
By lifting up the device cover, the FRED PA-1 starts up immediately and guides the rescuer step-by-step during the entire resuscitation process. The FRED PA-1 is available either as semi-automatic or fully automatic device.In its automatic version,...